These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin. Allen JH; Thakker KM; Small RE; Wood JH; Willis HE Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933 [No Abstract] [Full Text] [Related]
7. Spreadable dispersion of insect sex pheromone capsules, preparation via complex coacervation and release control of the encapsulated pheromone component molecule. Kong XZ; Gu X; Zhu X; Zhang Z Biomed Microdevices; 2009 Feb; 11(1):275-85. PubMed ID: 18821015 [TBL] [Abstract][Full Text] [Related]
9. [Clinical studies with a delayed-action sulfonamide, Sulfaclomide]. Heise GW; Paul G Z Urol Nephrol; 1969; 62(4):303-6. PubMed ID: 5403763 [No Abstract] [Full Text] [Related]
10. [Production and testing of peroral solid drug forms with delayed-action effect. Testing the effectiveness of using modified-isolated gelatin films in the production of microcapsules]. Moldenhauer H; Kala H Pharmazie; 1973; 28(11):773-7. PubMed ID: 4791267 [No Abstract] [Full Text] [Related]
11. [Intraoralia containing gelatin--a dissolution model and means of influencing dissolution behavior]. Voigt R; Werchan D Pharmazie; 1986 Jan; 41(1):33-8. PubMed ID: 3960946 [TBL] [Abstract][Full Text] [Related]
12. In vivo drug release rate from hard gelatin capsules. Wood JH J Pharm Sci; 1965 Aug; 54(8):1207-8. PubMed ID: 5882232 [No Abstract] [Full Text] [Related]
13. [Release of active substance from enteric-coated gelatine capsules in vivo and in vitro. 4. Study with pH-endoradioprobe in human]. Eckert T; Cordes G; Seidel R Arzneimittelforschung; 1971 Sep; 21(9):1403-6. PubMed ID: 5171798 [No Abstract] [Full Text] [Related]
14. [Rectal drug forms]. Azhgikhin IS Farmatsiia; 1968; 17(3):82-7. PubMed ID: 4930405 [No Abstract] [Full Text] [Related]
15. [Comparison of the elimination of glycerylguaiacol administered in the form of rectal capsules with various complex excipients and in the form of suppositories with former excipients]. Febvre P; Gisclon D Therapie; 1966; 21(6):1599-606. PubMed ID: 6002656 [No Abstract] [Full Text] [Related]
16. [Pellet technology. Sustained-release pellets in hard gelatin capsules--a suitable dosage form for theophylline]. Laicher A; Fuchs WS Arzneimittelforschung; 1998 May; 48(5A):540-7. PubMed ID: 9676341 [TBL] [Abstract][Full Text] [Related]
17. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Cole ET; Cadé D; Benameur H Adv Drug Deliv Rev; 2008 Mar; 60(6):747-56. PubMed ID: 18096270 [TBL] [Abstract][Full Text] [Related]
18. [On the evaluation of breaking substances in tablets]. Modrzejewski F; Wochna L Pharmazie; 1966 Jun; 21(6):355-8. PubMed ID: 6000985 [No Abstract] [Full Text] [Related]
19. [Influence of sliding agents on the rate of dissolution of acetylsalicylic acid in gel capsules]. Merle C; Artaud M; Guyot-Hermann AM Farmaco Prat; 1979 May; 34(5):210-9. PubMed ID: 456558 [No Abstract] [Full Text] [Related]
20. The effect of additives on the release of drug from hard gelatin capsules. Newton JM; Rowley G; Törnblom JF J Pharm Pharmacol; 1971 Jun; 23(6):452-3. PubMed ID: 4397188 [No Abstract] [Full Text] [Related] [Next] [New Search]